scholarly article | Q13442814 |
P2093 | author name string | Tao Wang | |
Jonathan A Epstein | |||
Thomas Huebner | |||
Anne Granger | |||
Peter J Gruber | |||
Ibrahim Abdullah | |||
Andrea Stout | |||
Faith Huebner | |||
P2860 | cites work | mHDA1/HDAC5 histone deacetylase interacts with and represses MEF2A transcriptional activity | Q22253463 |
Activation of the myocyte enhancer factor-2 transcription factor by calcium/calmodulin-dependent protein kinase-stimulated binding of 14-3-3 to histone deacetylase 5 | Q24290618 | ||
CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy | Q24293269 | ||
Histone deacetylase inhibitors repress the transactivation potential of hypoxia-inducible factors independently of direct acetylation of HIF-alpha | Q24308024 | ||
The language of covalent histone modifications | Q27860931 | ||
Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1 | Q28141355 | ||
Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy | Q28219383 | ||
Histone deacetylase 7 associates with hypoxia-inducible factor 1alpha and increases transcriptional activity | Q28274440 | ||
Histone deacetylase 4 controls chondrocyte hypertrophy during skeletogenesis | Q28505748 | ||
Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity | Q28508698 | ||
Histone deacetylases 5 and 9 govern responsiveness of the heart to a subset of stress signals and play redundant roles in heart development | Q28592216 | ||
Acetylation: a regulatory modification to rival phosphorylation? | Q29614886 | ||
Histone deacetylase inhibitors and the promise of epigenetic (and more) treatments for cancer | Q29615649 | ||
Histone methylation in transcriptional control | Q29616553 | ||
Histone and chromatin cross-talk | Q29617179 | ||
Hypoxia-activated apoptosis of cardiac myocytes requires reoxygenation or a pH shift and is independent of p53. | Q33853515 | ||
Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin | Q34188997 | ||
Histone acetylation and chromatin remodeling | Q34219273 | ||
MRL mice fail to heal the heart in response to ischemia-reperfusion injury. | Q34411234 | ||
Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha | Q34519869 | ||
Heart disease and stroke statistics--2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q34595917 | ||
Ischemic insults promote epigenetic reprogramming of mu opioid receptor expression in hippocampal neurons | Q35676840 | ||
Linking covalent histone modifications to epigenetics: the rigidity and plasticity of the marks | Q36238549 | ||
Endothelial barrier disruption by VEGF-mediated Src activity potentiates tumor cell extravasation and metastasis | Q36322698 | ||
Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine, and serotonin | Q36366651 | ||
Ischemic epigenetics and the transplanted kidney | Q38306439 | ||
Class II histone deacetylases are associated with VHL-independent regulation of hypoxia-inducible factor 1 alpha | Q40236336 | ||
Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. | Q40244153 | ||
Src blockade stabilizes a Flk/cadherin complex, reducing edema and tissue injury following myocardial infarction | Q40643967 | ||
Caveolae and vesiculo-vacuolar organelles in bovine capillary endothelial cells cultured with VPF/VEGF on floating Matrigel-collagen gels | Q40980631 | ||
Endothelin ET(B) receptor-mediated mechanisms involved in oleic acid-induced acute lung injury in mice | Q42525135 | ||
Histone deacetylases inhibitors as anti-angiogenic agents altering vascular endothelial growth factor signaling | Q43873079 | ||
Inhibitory effect of a novel bradykinin B1 receptor antagonist, R-954, on enhanced vascular permeability in type 1 diabetic mice | Q44300932 | ||
Lack of Apaf-1 expression confers resistance to cytochrome c-driven apoptosis in cardiomyocytes | Q44559477 | ||
Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee | Q45002081 | ||
Silent information regulator 2alpha, a longevity factor and class III histone deacetylase, is an essential endogenous apoptosis inhibitor in cardiac myocytes | Q45108317 | ||
Pathophysiological consequences of VEGF-induced vascular permeability | Q46349878 | ||
Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury | Q46990138 | ||
Vascular permeability factor/vascular endothelial cell growth factor-mediated permeability occurs through disorganization of endothelial junctional proteins. | Q48010453 | ||
Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action. | Q48235397 | ||
Effects of cerebral ischemia in mice lacking DNA methyltransferase 1 in post-mitotic neurons | Q48701586 | ||
DNA methyltransferase contributes to delayed ischemic brain injury. | Q52972663 | ||
Vascular endothelial growth factor induces rapid phosphorylation of tight junction proteins occludin and zonula occluden 1. A potential mechanism for vascular permeability in diabetic retinopathy and tumors | Q78101810 | ||
Inhibition of histone deacetylase on ventricular remodeling in infarcted rats | Q80076073 | ||
Pleiotropic role of histone deacetylases in the regulation of human adult erythropoiesis | Q80182843 | ||
P433 | issue | 10 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | reperfusion injury | Q1413991 |
P304 | page(s) | 3549-60 | |
P577 | publication date | 2008-10-01 | |
P1433 | published in | FASEB Journal | Q520194 |
P1476 | title | Histone deacetylase inhibition reduces myocardial ischemia-reperfusion injury in mice | |
P478 | volume | 22 |